Investegate |Prothena Corporation plc Announcements | Prothena Corporation plc: Prothena to Participate in Stifel 2022 Virtual CNS Days
Investegate announcements from Prothena Corporation plc, Prothena to Participate in Stifel 2022 Virtual CNS Days
Stay updated with breaking news from Eric Endicott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Prothena Corporation plc, Prothena to Participate in Stifel 2022 Virtual CNS Days
DUBLIN, Ireland, March 21, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein
Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022 - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Oral presentation on preclinical data demonstrates Prothena's dual Aß/tau vaccine, for the potential treatment and prevention of Alzheimer's, generated anti-Aß and anti-tau antibodies to enable phagocytosis